Monoclonal antibody induced with inactived EV71-Hn2 virus protects mice against lethal EV71-Hn2 virus infection

Virology Journal

Volumn 7, Issue 1, 2010, Pages

  Chang, Guo Hui ^a   Luo, Yan Jun ^a   Wu, Xiao Yan ^a   Si, Bing Yin ^a   Lin, Lei ^a   Zhu, Qing Yu ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 1A5; MONOCLONAL ANTIBODY 2F7; MONOCLONAL ANTIBODY 3B11; MONOCLONAL ANTIBODY 4C6; MONOCLONAL ANTIBODY 4D10; MONOCLONAL ANTIBODY 4E8; MONOCLONAL ANTIBODY 4G9; NEUTRALIZING ANTIBODY; PROTEIN VP1; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS PROTEIN; VIRUS VACCINE;

ADULT; AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY ISOLATION; ANTIGEN ANTIBODY REACTION; ARTICLE; CONTROLLED STUDY; ENTEROVIRUS A71; ENTEROVIRUS A71 HENAN2 VIRUS STRAIN; ENTEROVIRUS INFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNIZATION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; VIRUS NEUTRALIZATION; VIRUS PURIFICATION; VIRUS STRAIN; ANIMAL; BAGG ALBINO MOUSE; CELL LINE; CHEMISTRY; ENTEROVIRUS; GENETICS; IMMUNOLOGY; MOLECULAR GENETICS; PASSIVE IMMUNIZATION; SEQUENCE ALIGNMENT; VIROLOGY;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; CELL LINE; ENTEROVIRUS A, HUMAN; ENTEROVIRUS INFECTIONS; FEMALE; HUMANS; IMMUNIZATION, PASSIVE; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; SEQUENCE ALIGNMENT; VIRAL PROTEINS; VIRAL VACCINES;

EID: 77952625762     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-7-106     Document Type: Article

References (28)

1. Schmidt NJ, Lennette EH, Ho HH: An apparently new enterovirus isolated from patients with disease of the central nervous system. J Infect Dis 1974, 129:304-309.
2. Hagiwara A, Yoneyama T, Takami S, Hashimoto I: Genetic and phenotypic characteristics of enterovirus 71 isolates from patients with encephalitis and with hand, foot and mouth disease associated with enterovirus 71 infection. Arch Virol 1984, 79:273-283.
3. Mizuta K, Abiko C, Murata T, Matsuzaki Y, Itagaki T, Sanjoh K, Sakamoto M, Hongo S, Murayama S, Hayasaka K: Frequent importation of Enterovirus 71 from surrounding countries into the local community of Yamagata, Japan, between 1998 and 2003. J Clin Microbio 2005, 43:6171-6175.
4. Chumakov M, Voroshilova M, Shindarov L, Lavrova I, Gracheva L, Koroleva G: Enterovirus 71 isolated from cases of epidemic poliomyelitis-like disease in Bulgaria. Arch Virol 1979, 60:329-340.
5. Abubakar S, Chee HY, Shafee N, Chua KB, Lam SK: Molecular detection of enteroviruses from an outbreak of hand, foot and mouth disease in Malaysia in 1997. Scand J Infect Dis 1999, 31:331-335.
6. Ho M, Chen ER, Hsu KH, Twu SJ, Chen KT, Tsai SF: An epidemic of enterovirus 71 infection in Taiwan. New Engl J Med 1999, 341:929-935.
7. Li RQ, Chen LJ, Wang YM, Zhang HR, He X: Genetic characteristics of enterovirus 71 isolated in Beijing, 2006-2008. Zhonghua Liu Xing Bing Xue Za Zhi 2009, 30:45-49. Chinese
8. Lin L, He YQ, Hong Y, Zhu JP: Genetic Characteristics of Human Enterovirus 71 and Coxsackievirus A16 Circulating from 1999 to 2004 in Shenzhen, People's Republic of China. J Clin Microbio 2005, 43:3835-3839.
9. Chang GH, Lin L, Luo YJ, Cai LJ, Wu XY, Xu HM, Zhu QY: Sequence analysis of six enterovirus 71 strains with different virulences in humans. Virus Res 2010, 151:66-73.
10. Da Silva EE, Winkler MT, Pallansch MA: Role of enterovirus 71 in acute flaccid paralysis after the eradication of poliovirus in Brazil. Emerg Infect Dis 1996, 2:231-233.
11. Brown BA, Pallansch MA: Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus. Virus Res 1995, 39:195-205.
12. Foo DGW, Alonso S, Phoon MC, Ramachandran NP, Chow VTK, Poh CL: Identification of neutralizing linear epitopes from the VP1 capsid protein of enterovirus 71 using synthetic peptides. Virus Res 2007, 125:61-68.
13. Guang DM, Foo W, Alonso S, Chow VTK, Poh CL: Passive protection against lethal enterovirus 71 infection in newborn mice by neutralizing antibodies elicited by a synthetic peptide. Microbes Infect 2007, 9:1299-1306.
14. Chiu CH, Chu C, He CC, Lin TY: Protection of neonatal mice from lethal enterovirus 71 infection by maternal immunization with attenuated Salmonella enterica serovar Typhimurium expressing VP1 of enterovirus 71. Microbes Infect 2006, 8:1-8.
15. Wu CN, Lin YC, Fann C, Liao NS, Shih SR, Ho MS: Protection against enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus. Vaccine 2001, 20:895-904.
16. Kolaskar AS, Tongaonkar PC: A semi-empirical method for prediction of antigenic determinants on protein antigens. FEBS Lett 1990, 276:172-174.
17. McMinn PC: An overview of the evolution of Enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev 2002, 26:91-107.
18. Blomberg J, Lycke E, Ahlfors K, Johnsson T, Wolontis S, Von Ziepe GI: New enterovirus type associated with epidemic of aseptic menigitis and: or hand, foot, and mouth disease. Lancet 1974, 2:112-119.
19. Huang CC, Liu CC, Chang YC, Chen CY, Wang ST, Yeh TF: Neurologic complications in children with enterovirus 71 infection. N Engl J Med 1999, 341:936-942.
20. Kimura-Kuroda J, Yasui K: Protection of mice against Japanese encephalitis virus by passive administration with monoclonal antibodies. J Immunol 1988, 141:3606-3610.
21. Huang YC, Lin TY, Lin YJ, Lien RI, Chou YH: Prophylaxis of intravenous immunoglobulin and acyclovir in perinatal varicella. Eur J Pediatr 2001, 160:91-94.
22. Geller TJ, Condie D: A case of protracted coxsackie virus meningoencephalitis in a marginally immunodeficient child treated successfully with intravenous immunoglobulin. J Neurol Sci 1995, 129:131-133.
23. Thomas AAM, Brioen P, Boye A: A monoclonal antibody that neutralizes poliovirus by cross-linking virions. J of Virol 1985, 54:7-13.
24. Smith TJ, Olson NH, Cheng RH, Chase ES, Baker TS: Structure of a human rhinovirus-bivalently bound antibody complex: implications for viral neutralization and antibody flexibility. Proceedings of the National Academy of Sciences. USA 1993, 90:7015-7018.
25. Lal SK, Kumar P, Yeo WM, Kar-Roy A, Chow VT: The VP1 protein of human Enterovirus 71 self-associates via an interaction domain spanning amino acids 66-297. J Med Virol 2006, 78:582-590.
26. Tan CS, Cardosa MJ: High-titred neutralizing antibodies to human enterovirus 71 preferentially bind to the N-terminal portion of the capsid protein VP1. Arch Virol 2007, 152:1069-1073.
27. Reed LJ, Muench H: A simple method of estimating 50 percent end-points. Am J Hyg 1938, 27:493-497.
28. Kohler G, Milstein C: Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975, 256:495-497.